Vincerx Pharma Announces Redemption of Public Warrants
05 avr. 2021 08h00 HE
|
Vincerx Pharma, Inc.
PALO ALTO, Calif., April 05, 2021 (GLOBE NEWSWIRE) -- Vincerx Pharma, Inc. (Nasdaq: VINC) (the “Company”), today announced that it will redeem all of its outstanding public warrants (the “Public...
Vincerx Pharma Announces Formation of Scientific Advisory Board to Advance its Clinical Pipeline
01 avr. 2021 08h00 HE
|
Vincerx Pharma, Inc.
PALO ALTO, Calif., April 01, 2021 (GLOBE NEWSWIRE) -- Vincerx Pharma, Inc. (Nasdaq: VINC), a biopharmaceutical company aspiring to address the unmet medical needs of patients with cancer through...
Vincerx Pharma Reports Fourth Quarter and Full Year 2020 Financial Results and Provides a Corporate Update
23 mars 2021 08h00 HE
|
Vincerx Pharma, Inc.
License agreement with Bayer AG secures oncology portfolio including clinical-stage PTEFb/CDK9 inhibitor with encouraging Phase 1 activity Successful completion of business combination transaction,...
Vincerx Pharma Announces Poster Presentation at the American Association for Cancer Research (AACR) Annual Meeting 2021
10 mars 2021 16h32 HE
|
Vincerx, Inc.
PALO ALTO, Calif., March 10, 2021 (GLOBE NEWSWIRE) -- Vincerx Pharma, Inc. (Nasdaq: VINC), a biopharmaceutical company aspiring to address the unmet medical needs of patients with cancer through...
Vincerx Pharma Strengthens Management Team with Three New Appointments
02 mars 2021 08h00 HE
|
Vincerx, Inc.
PALO ALTO, Calif., March 02, 2021 (GLOBE NEWSWIRE) -- Vincerx Pharma, Inc. (Nasdaq: VINC), a biopharmaceutical company aspiring to address the unmet medical needs of patients with cancer through...
Vincerx Pharma To Host Key Opinion Leader Webinar on VIP152 for the Treatment of Hematologic and Solid Tumors
24 févr. 2021 08h00 HE
|
Vincerx, Inc.
PALO ALTO, Calif., Feb. 24, 2021 (GLOBE NEWSWIRE) -- Vincerx Pharma, Inc. (Nasdaq: VINC), a biopharmaceutical company aspiring to address the unmet medical needs of patients with cancer through...
Vincerx Pharma to Participate in the 10th Annual SVB Leerink Global Healthcare Conference
17 févr. 2021 08h00 HE
|
Vincerx, Inc.
PALO ALTO, Calif., Feb. 17, 2021 (GLOBE NEWSWIRE) -- Vincerx Pharma, Inc. (Nasdaq: VINC), a biopharmaceutical company aspiring to address the unmet medical needs of patients with cancer through...
Vincera Pharma Announces Name Change to Vincerx
07 janv. 2021 16h01 HE
|
Vincerx, Inc.
PALO ALTO, Calif., Jan. 07, 2021 (GLOBE NEWSWIRE) -- Vincerx Pharma, Inc. (Nasdaq: VINC), a biopharmaceutical company aspiring to address the unmet medical needs of patients with cancer through...
Vincera Pharma Announces Completion of Business Combination and Listing on Nasdaq
23 déc. 2020 10h25 HE
|
Vincera Pharma, Inc.
Business combination transaction with LifeSci Acquisition Corp. was completed on December 23, 2020 Combined company renamed Vincera Pharma, Inc., common stock commences trading tomorrow, December 24,...
Vincera Pharma, Inc Announces Exclusive License Agreement for Oncology Portfolio Including a Clinical-stage PTEFb/CDK9 Inhibitor and a Preclinical Bioconjugation Platform
08 oct. 2020 08h00 HE
|
Vincera Pharma, Inc.
Portfolio includes VIP152, a highly selective PTEFb/CDK9 inhibitor with encouraging Phase 1 monotherapy activity, including complete responses in DH-DLBCL Vincera intends to pursue multiple...